The PRESERVE Trial: Prevention of Serious Adverse Events following angiography

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1011387

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

More than 75,000 coronary angiograms are performed each year in Australia. The dye used in angiograms can cause acute kidney injury (AKI); with diabetes, pre-existing kidney disease and heart failure putting people at high risk. Consequences include irreversible kidney failure requiring dialysis and risk of death. Little evidence support currently used prevention strategies. The PRESERVE Trial will recruit 5,200 people to provide definitive evidence to guide prevention of AKI.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $2,424,334.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nephrology and Urology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

angiography | clinical trial | kidney disease | kidney failure

Related Links